Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13086215 | 0.89 | CNR2 (0.41) | ALDH1A1MAPTKMT2AKEAP1NFE2L2 | |
| SCHEMBL13086504 | 0.84 | SMN1; SMN2 (0.43) | LMNAALDH1A1CYP2D6SMN1; SMN2KMT2A | |
| SCHEMBL6302951 | 0.82 | CNR2 (0.47) | ALDH1A1TSHRMAPTKMT2ACNR2 | |
| SCHEMBL31037871 | 0.80 | SRC (0.48) | LMNAALDH1A1TSHRGMNNCYP2D6 | |
| SCHEMBL17491037 | 0.80 | CNR2 (0.41) | ALDH1A1TSHRMAPTKMT2AKEAP1 | |
| SCHEMBL13084367 | 0.78 | GMNN (0.38) | LMNAALDH1A1TSHRGMNNCYP2D6 | |
| SCHEMBL2805280 | 0.78 | KMT2A (0.50) | LMNAALDH1A1TSHRGMNNCYP2D6 | |
| SCHEMBL15456978 | 0.77 | GMNN (0.37) | LMNAALDH1A1TSHRGMNNCYP2D6 | |
| SCHEMBL15998117 | 0.77 | TP53 (0.34) | LMNAALDH1A1MAPTKMT2ARAB9A | |
| Toluene SCHEMBL3695876 | 0.77 | KMT2A (0.47) | LMNAALDH1A1TSHRMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200199369-A9 | LUMINESCENT SQUARAINE ROTAXANE COMPOUNDS | SETA BIOMEDICALS, LLC | 2020-06-25 | — | — | US | disclosed |
| US-20190048196-A1 | LUMINESCENT SQUARAINE ROTAXANE COMPOUNDS | SETA BIOMEDICALS LLC (US) | 2019-02-14 | — | — | US | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | LMNA 985/4885ALDH1A1 2552/4885TSHR 3692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.